IRIS
Cao, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 732
EU - Europa 341
AS - Asia 231
AF - Africa 12
OC - Oceania 1
SA - Sud America 1
Totale 1.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 727
FI - Finlandia 148
CN - Cina 112
SG - Singapore 82
IE - Irlanda 78
DE - Germania 36
SE - Svezia 30
IN - India 25
IT - Italia 18
GB - Regno Unito 10
NG - Nigeria 10
FR - Francia 9
TH - Thailandia 4
CU - Cuba 3
JP - Giappone 3
RU - Federazione Russa 3
CA - Canada 2
EG - Egitto 2
NL - Olanda 2
PT - Portogallo 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IR - Iran 1
RO - Romania 1
RS - Serbia 1
TR - Turchia 1
Totale 1.318
Salva come PNG Salva come JPEG
Città #
Helsinki 148
Boardman 102
Shanghai 96
Chandler 90
Dublin 78
Singapore 56
New York 53
Ashburn 49
Wilmington 48
Los Angeles 25
San Mateo 24
Pune 18
Ann Arbor 16
Seattle 12
Santa Clara 11
Benin City 10
Lawrence 10
Princeton 10
Leawood 9
Milan 9
Fairfield 6
Abbiategrasso 5
Paris 5
Phoenix 5
Woodbridge 4
Havana 3
London 3
Phuket 3
Amsterdam 2
Falkenstein 2
Giza 2
Hackney 2
Ho Chi Minh City 2
Lübeck 2
Moscow 2
Mumbai 2
Munich 2
New Delhi 2
Norwalk 2
San Diego 2
Shijiazhuang 2
Surat 2
Brno 1
Chengdu 1
Chennai 1
Chicago 1
Chongqing 1
Clifton 1
Cologno Monzese 1
Des Moines 1
Hangzhou 1
Huddersfield 1
Istanbul 1
Kashan 1
Kemerovo 1
Kunming 1
League City 1
Leeds 1
Lisbon 1
Mladenovac 1
Rome 1
Sam Phran 1
San Francisco 1
Sankt Augustin 1
Stockholm 1
São Paulo 1
Tappahannock 1
Toronto 1
Tübingen 1
Vienna 1
Zhoukou 1
Totale 965
Salva come PNG Salva come JPEG
Nome #
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach 64
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 62
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 62
The synergy stent in high-bleeding risk patients: why design matters 49
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 41
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 39
Short Versus Long Duration of DAPT After DES Implantation: A Meta-Analysis. 36
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 33
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 25
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents 23
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 22
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 22
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 22
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 22
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 21
Revascularization in patients with valvular heart disease 21
Device profile of the Resolute Onyx Zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy 20
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 19
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 19
Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention 18
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 18
Contrast-induced acute kidney injury 18
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 17
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 17
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index 17
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients 17
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike 16
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation 16
Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better 16
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 15
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial 15
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 15
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 15
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes 14
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI 14
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 14
Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome 14
Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies 14
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 13
From surgical clamping to endovascular flow arrest/reversal: the concept behind the system 13
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent 13
Depression and ischemic heart disease 13
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 13
Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management 12
Minding the Microcirculation: Is it Worth the Effort? 12
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI 12
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 12
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction 12
Clopidogrel Monotherapy After 1-Month DAPT in Diabetic Patients Undergoing PCI: Is Less Always More? 12
Ticagrelor in Patients With Cancer: 2 Birds With 1 Stone 11
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 11
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 11
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 10
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry 10
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis 10
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 10
Sodium Bicarbonate, Contrast-Associated Acute Kidney Injury, and Long-Term Outcomes: The End of an Era? 10
Stick to the guidelines or clinical judgment: A toss up? 10
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 10
Types of myocardial injury and mid-term outcomes in patients with COVID-19 9
Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention 9
Ticagrelor With or Without Aspirin in High-Risk Patients With Anemia Undergoing Percutaneous Coronary Intervention: a subgroup analysis of the TWILIGHT trial 9
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 9
The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry 9
Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI 9
Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris 8
Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review 8
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR 8
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial 8
Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI 8
Ticagrelor Monotherapy After Coronary Stenting: Is the GLASS Half Full or Half Empty? 8
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study 8
New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention 7
Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry 7
Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria 7
Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG 7
Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess? 7
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7 7
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI 7
Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon 7
Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week 7
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD 7
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 7
Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost 6
First and recurrent events in the ISCHEMIA trial: two sides of the same coin 6
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease 6
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study 5
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis 5
Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention 5
Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and design 4
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program 4
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD 4
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease 3
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials 2
Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes 2
Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention 2
Totale 1.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.566
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 1 0 3 0 0 24 17 7 26 13 0 10
2021/202257 3 2 0 13 2 1 0 6 5 2 15 8
2022/2023487 21 5 13 43 33 30 77 27 92 99 38 9
2023/2024686 69 51 152 37 12 84 51 14 23 37 81 75
2024/202572 22 3 17 11 19 0 0 0 0 0 0 0
Totale 1.403